Effect of metalloproteinase from Staphylococcus aureus on in vitro stimulation of human lymphocytes

Immunol Lett. 1991 Mar;27(3):225-30. doi: 10.1016/0165-2478(91)90156-5.

Abstract

Metalloproteinase (MP) produced by the majority of Staphylococcus aureus strains exerts, in a wide concentration range (0.1-100 micrograms/ml), no cytotoxic action on mononuclear leukocytes of human peripheral blood. The enzyme itself does not appreciably stimulate proliferation and differentiation of lymphocytes in culture, but affects the stimulation of both T and B lymphocytes by polyclonal activators. The action is dose-dependent. High doses of MP (100 micrograms/ml) lower the blastic transformation after stimulation with Con A, SpA, NDCM, S. aureus strain Wood 46 and with suboptimal doses of PWM. Optimal concentrations of the enzyme potentiate the stimulation of lymphocytes by PWM, PHA, S. aureus strains Cowan 1 and Wood 46, and by NDCM. The same potentiation effect was achieved whether the enzyme was added concurrently with the mitogen or 18 h later. This implies that the beginning of cell activation is not affected. A high MP concentration decreases the production of Ig in culture after stimulation with PWM whereas lower concentrations of MP enhance this production. Production of Ig after stimulation with NDCM and Wood 46 is decreased by MP. The possible action of exoproteinase from S. Aureus on the immune response during infection is discussed.

MeSH terms

  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Humans
  • Immunoglobulins / analysis
  • Immunoglobulins / biosynthesis*
  • Kinetics
  • Lymphocyte Activation / drug effects*
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Metalloendopeptidases / pharmacology*
  • Mitogens / pharmacology
  • Staphylococcus aureus / enzymology*

Substances

  • Immunoglobulins
  • Mitogens
  • Metalloendopeptidases
  • auR protein, Staphylococcus aureus